V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220021638 | 220016728 | 1.87 | 83 | Adjuvant (A) | 2018-11-13 | 2018-12-29 | Azacitidine | 2 | N | 220010724 | AZACITIDINE |
| 220021639 | 220004499 | 1.79 | 77.8 | null | 2017-03-16 | 2017-03-17 | DA 3 + 10 | N | N | 220010808 | DA |
| 220021640 | 220004503 | null | 78.2 | Curative (C) | 2014-08-24 | 2014-08-27 | DA 3+8 | 2 | N | 220010889 | DA |
| 220021641 | 220004509 | 1.73 | 77 | Palliative (P) | 2016-12-21 | 2018-12-09 | Azacitidine | N | N | 220011008 | AZACITIDINE |
| 220021642 | 220004539 | 1.82 | null | Curative (C) | null | 2017-01-25 | DA 3+8 | 02 | null | 220011747 | DA |
| 220021643 | 220004552 | 1.24 | 93.2 | Curative (C) | 2013-10-28 | 2013-10-29 | Azacitidine | Y | N | 220012142 | AZACITIDINE |
| 220021644 | 220004558 | 1.53 | 65 | Curative (C) | 2018-01-15 | 2018-01-15 | DA | Y | N | 220012148 | DA |
| 220021645 | 220004563 | 1.6 | 45.8 | null | 2015-12-30 | 2016-02-21 | DA 3+8 | N | N | 220012344 | DA |
| 220021646 | 220019223 | 1.66 | 71.6 | null | 2017-04-27 | 2017-06-13 | DA | N | N | 220012451 | DA |
| 220021647 | 220012406 | 1.72 | 107 | Curative (C) | 2016-03-10 | 2016-03-21 | DA 3 + 10 | Y | N | 220012541 | DA |
| 220021648 | 220004583 | 1.77 | 86 | Curative (C) | 2017-05-18 | 2017-05-18 | CYTARABINE + DAUNORUBICIN | N | N | 220012770 | DA |
| 220021649 | 220004586 | null | 62 | null | 2015-03-14 | 2015-03-14 | Azacitidine | N | N | 220012814 | AZACITIDINE |
| 220021650 | 220004591 | null | null | null | 2017-11-05 | 2017-11-09 | Nilotinib | 02 | N | 220012841 | NILOTINIB |
| 220021651 | 220012419 | 1.7 | null | Curative (C) | 2016-10-01 | 2016-10-02 | Cytarabine High Dose | N | N | 220012906 | CYTARABINE HIGH DOSE |
| 220021652 | 220004623 | 0 | 0 | null | 2017-05-08 | 2017-05-08 | Nilotinib | 2 | N | 220013701 | NILOTINIB |
| 220021653 | 220004675 | null | 87.3 | Disease modification (D) | 2017-12-12 | 2017-12-12 | Nilotinib | N | N | 220015129 | NILOTINIB |
| 220021654 | 220004679 | 0 | 0 | Curative (C) | 2018-06-17 | 2019-03-26 | Nilotinib | 2 | N | 220015258 | NILOTINIB |
| 220021655 | 220004686 | 1.73 | 90.1 | Curative (C) | 2018-06-02 | 2018-06-05 | Cytarabine High Dose | 02 | N | 220015369 | CYTARABINE HIGH DOSE |
| 220021658 | 220004726 | 0 | 0 | Curative (C) | 2014-02-01 | 2014-08-03 | Nilotinib | N | N | 220016177 | NILOTINIB |
| 220021663 | 220004777 | 0 | 0 | null | 2015-02-15 | 2015-11-27 | Nilotinib | 02 | N | 220017427 | NILOTINIB |
| 220021664 | 220012540 | 1.71 | 0 | Disease modification (D) | 2013-02-26 | 2014-02-26 | Nilotinib | N | N | 220018824 | NILOTINIB |
| 220021666 | 220004844 | 1.56 | 47.6 | Curative (C) | 2015-06-16 | 2015-08-27 | Cytarabine High Dose | N | N | 220018973 | CYTARABINE HIGH DOSE |
| 220021667 | 220004851 | 1.7 | null | null | 2014-11-22 | 2014-11-22 | AML Int Guide HD Cytarabine (3 + 4) | 02 | N | 220019038 | CYTARABINE HIGH DOSE |
| 220021668 | 220004880 | 1.71 | 88.6 | Curative (C) | 2016-10-23 | 2016-10-23 | AML Int Guide HD Cytarabine (3 + 4) | 99 | N | 220019484 | CYTARABINE HIGH DOSE |
| 220021669 | 220012580 | 1.64 | 76 | Disease modification (D) | 2016-06-25 | 2016-06-25 | Nilotinib | N | N | 220019680 | NILOTINIB |
| 220021670 | 220004915 | 1.68 | 79 | Curative (C) | 2013-07-23 | 2013-07-27 | Cytarabine High Dose | N | null | 220019791 | CYTARABINE HIGH DOSE |
| 220021671 | 220004918 | 1.67 | 96 | Curative (C) | 2017-10-09 | 2017-10-09 | Cytarabine High Dose | N | N | 220019796 | CYTARABINE HIGH DOSE |
| 220021672 | 220004922 | 1.68 | 62.5 | Palliative (P) | 2015-12-31 | 2016-01-15 | Cytarabine High Dose | 99 | N | 220019798 | CYTARABINE HIGH DOSE |
| 220021673 | 220004928 | 1.68 | 86 | Curative (C) | null | 2014-02-24 | AML Int Guide HD Cytarabine (3 + 4) | N | N | 220019810 | CYTARABINE HIGH DOSE |
| 220021674 | 220004958 | 1.72 | null | Disease modification (D) | 2014-05-05 | 2016-02-17 | Nilotinib | 99 | N | 220019862 | NILOTINIB |
| 220021675 | 220004964 | 1.73 | 68.9 | Palliative (P) | null | 2019-02-13 | Cytarabine High Dose | 99 | null | 220019873 | CYTARABINE HIGH DOSE |
| 220021676 | 220016894 | null | null | Curative (C) | 2016-05-31 | 2017-05-08 | Nilotinib | N | N | 220019888 | NILOTINIB |
| 220021677 | 220004989 | null | 74.5 | Curative (C) | 2015-10-24 | 2015-10-25 | Cytarabine High Dose | 02 | N | 220019911 | CYTARABINE HIGH DOSE |
| 220021678 | 220004993 | 1.8 | 72 | Disease modification (D) | 2014-06-12 | 2014-06-12 | AML Int Guide HD Cytarabine (3 + 4) | N | null | 220019932 | CYTARABINE HIGH DOSE |
| 220021679 | 220019303 | 1.6 | 82 | Curative (C) | 2015-01-16 | 2015-03-19 | Cytarabine High Dose | 2 | null | 220019939 | CYTARABINE HIGH DOSE |
| 220021680 | 220005044 | 1.71 | 63.9 | Curative (C) | null | 2013-11-24 | Cytarabine High Dose | 1 | N | 220020072 | CYTARABINE HIGH DOSE |
| 220021681 | 220012663 | 1.55 | null | Disease modification (D) | 2016-04-01 | 2016-04-01 | Nilotinib | 02 | N | 220020095 | NILOTINIB |
| 220021682 | 220005061 | null | 60.2 | Palliative (P) | null | 2017-03-27 | AML17 TRIAL | 2 | N | 220020111 | AML17 TRIAL |
| 220021683 | 220005085 | 1.71 | 68 | Not known (9) | 2017-02-08 | 2017-04-15 | FLAG + Idarubicin | null | null | 220020158 | FLAG + IDARUBICIN |
| 220021684 | 220005093 | 1.04 | null | Disease modification (D) | 2018-04-29 | 2018-04-29 | FLAG + Idarubicin | N | N | 220020160 | FLAG + IDARUBICIN |
| 220021685 | 220005132 | 1.6 | 58.5 | Curative (C) | 2014-08-17 | 2014-09-28 | AML17 TRIAL | N | N | 220020253 | AML17 TRIAL |
| 220021686 | 220005148 | 1.59 | 63.8 | Curative (C) | null | 2016-08-24 | FLAG + Idarubicin | N | N | 220020290 | FLAG + IDARUBICIN |
| 220021687 | 220005161 | 0 | 75 | Disease modification (D) | 2015-02-02 | 2015-02-02 | FLAG + Idarubicin | 02 | N | 220020301 | FLAG + IDARUBICIN |
| 220021688 | 220005167 | 1.72 | null | Curative (C) | 2017-07-19 | 2017-07-25 | AML17 TRIAL | 02 | N | 220020318 | AML17 TRIAL |
| 220021689 | 220016965 | 1.54 | 84.4 | Curative (C) | null | 2014-12-05 | AML17 TRIAL | N | N | 220020360 | AML17 TRIAL |
| 220021690 | 220016972 | 1.82 | 72.8 | Adjuvant (A) | 2014-07-23 | 2014-12-25 | FLAG + Idarubicin | 02 | N | 220020407 | FLAG + IDARUBICIN |
| 220021691 | 220005208 | 1.57 | 92.3 | Curative (C) | 2018-01-23 | 2018-01-27 | AML17 TRIAL | 1 | N | 220020414 | AML17 TRIAL |
| 220021692 | 220005219 | 1.65 | 76.3 | Curative (C) | 2017-03-19 | 2017-03-22 | AML17 TRIAL | N | N | 220020435 | AML17 TRIAL |
| 220021693 | 220005233 | null | 64.3 | Adjuvant (A) | 2013-09-17 | 2016-01-11 | AML17 TRIAL | 2 | null | 220020450 | AML17 TRIAL |
| 220021696 | 220005276 | 1.87 | 79.6 | Curative (C) | 2016-06-18 | 2016-07-21 | AML17 TRIAL | Y | N | 220020503 | AML17 TRIAL |